Kim Rodriguez was the President, CEO and Co-Founder of Acessa Health, Inc. who successfully sold to Hologic. Prior to Acessa Health, she served as president & CEO of Halt Medical. Prior to that, senior vice president of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Over the course of a 20+ year career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the commercialization of dozens of innovative medtech technologies and M&A transactions. Kim received her Executive MBA at the University of Southern California Marshall School of Business and B.S. in Management from Pepperdine University. We discussed being a FemTech exit, uterine fibroids and hysterectomies.
Check out the Acessa Health at www.acessaprocedure.com
Rate, Review & Subscribe!
Dec 21 2020
Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market. A bilingual Spanish/English executive with a career trajectory that spans organizational leadersh...Listen now
Dec 23 2020
Claire Rosario is the User Experience & IT Infrastructure consultant at Hyivy Health, a rehabilitation company developing products to improve pelvic health for womxn and vaginas everywhere. She has worked in IT infrastructure for over a decade wi...Listen now
Dec 28 2020
Gail Anderson is a Harvard-trained counselor with over 20 years of experience helping intended parents, and one of the fertility industry’s leading innovators and creative thinkers. After doing postgraduate research at Yale, she started two egg donor...Listen now